{"url":"https://lda.senate.gov/api/v1/filings/d79262b8-ccec-4e8a-9dee-819a15747536/","filing_uuid":"d79262b8-ccec-4e8a-9dee-819a15747536","filing_type":"RR","filing_type_display":"Registration","filing_year":2020,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/d79262b8-ccec-4e8a-9dee-819a15747536/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Robert James Horne","dt_posted":"2020-03-25T17:43:35-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"6905 Forest Hill Drive","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"University Park","registrant_state":"MD","registrant_zip":"20782","registrant":{"id":401105585,"url":"https://lda.senate.gov/api/v1/registrants/401105585/","house_registrant_id":44708,"name":"FOREST HILL CONSULTING","description":"Health policy, market, and advocacy consulting services","address_1":"6905 Forest Hill Drive","address_2":null,"address_3":null,"address_4":null,"city":"University Park","state":"MD","state_display":"Maryland","zip":"20782","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ROBERT HORNE","contact_telephone":"+1 703-217-8748","dt_updated":"2026-02-02T21:40:19.801493-05:00"},"client":{"id":205737,"url":"https://lda.senate.gov/api/v1/clients/205737/","client_id":12,"name":"AMAG PHARMACEUTICALS","general_description":"Pharmaceutical company.","client_government_entity":false,"client_self_select":null,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-10"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pharmaceutical lobbying issues related to women's health product access.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":141060,"prefix":"mr","prefix_display":"MR.","first_name":"ROBERT","nickname":null,"middle_name":"JAMES","last_name":"HORNE","suffix":null,"suffix_display":null},"covered_position":"Professional Staff, House Energy and Commerce Committee\nSenior Legislative Aide, Rep. Phil Gingrey (GA)\nLegislative Aide, Rep. Jeff Fortenberry (NE)","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}